MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$5,704K
Net Income
-$14,107K
Net Profit Margin
-247.32%
EPS
-$0.14
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
5,704
4,580
5,640
6,500
Research and development
16,131
13,601
17,992
21,708
General and administrative
5,027
5,156
4,996
5,210
Total operating expenses
21,158
18,757
22,988
26,918
Loss from operations
-15,454
-14,177
-17,348
-20,418
Other income, net
1,533
3,792
891
693
Net loss
-13,921
-10,385
-16,457
-19,725
Unrealized gain on marketable securities, net of tax
-186
-49
6
3
Comprehensive loss
-14,107
-10,434
-16,451
-19,722
Basic EPS
-0.14
-0.13
-0.206
-0.26
Diluted EPS
-0.14
-0.13
-0.206
-0.26
Basic Average Shares
98,388,593
82,519,981
79,712,217
76,132,337
Diluted Average Shares
98,388,593
82,519,981
79,712,217
76,132,337
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
PRLD Income Statement Sankey Diagram
Sankey diagram visualizing PRLD income statement for the period
Comprehensive loss
-$14,107K
(54.85%↑ Y/Y)
Net loss
-$13,921K
(55.43%↑ Y/Y)
Unrealized gain on
marketable securities, net...
-$186K
(-1330.77%↓ Y/Y)
Other income, net
$1,533K
(59.19%↑ Y/Y)
Loss from operations
-$15,454K
(52.00%↑ Y/Y)
Revenue
$5,704K
Total operating
expenses
$21,158K
(-34.28%↓ Y/Y)
Research and development
$16,131K
(-37.44%↓ Y/Y)
General and
administrative
$5,027K
(-21.58%↓ Y/Y)
Buy us a coffee
Prelude Therapeutics Inc (PRLD)
Prelude Therapeutics Inc (PRLD)